Mature Results of a Prospective Randomized Trial Comparing 5-Flourouracil with Leucovorin to 5-Flourouracil with Levamisole as Adjuvant Therapy of Stage II and III Colorectal Cancer- The Israel Cooperative Oncology Group (ICOG) Study

Objective: Survival benefit with adjuvant therapy was shown in patients with Stage III colorectal cancer (CRC). This study evaluates long-term (10-year) outcome in patients with CRC randomly assigned to adjuvant 5-Fluorouracil/Leucovorin (5FU+LV) or 5-FU/Levamisole (5FU+LEV). Methods: Between 1990 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Figer, Arie, Nissan, Aviram, Shani, Adi, Borovick, Riva, Stiener, Mariana, Baras, Mario, Freund, Herbert R., Sulkes, Aaron, Stojadinovic, Alexander, Peretz, Tamar
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069353/
https://www.ncbi.nlm.nih.gov/pubmed/21475636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069353/
https://www.ncbi.nlm.nih.gov/pubmed/21475636

Ejemplares similares